Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,043 total articles
IonQ combines industry-leading trapped-ion gate fidelity with accelerating commercial traction and explicit government procurement tailwinds. Valuation is rich, but recent multiple de-rate and improving revenue trends create an asymmetric mid-to-long-term trade. Plan: enter at $49.00, trail risk to $40.00, target $70.00 over a 180 trading-day horiz…
TransDigm (TDG) is a cash-generative aerospace components specialist trading at a premium but supported by a 47% operating margin, recurring aftermarket sales, $1.85B free cash flow and targeted acquisitions. We upgrade to Strong Buy with an entry of $1346.92, a $1600 target (180 trading days) and a $1200 stop loss. Catalysts include M&A integratio…
United Therapeutics (UTHR) is trading with favorable fundamentals and a clear catalyst cadence: a string of 2026 Tyvaso filings, stronger PAH pipeline readouts, and meaningful shareholder repurchases. At roughly $547 today, the stock offers a mix of near-term regulatory re-ratings and durable cash flow that justify a buy with a disciplined stop. Th…
After months of retail-driven volatility and headline chasing, Reddit looks positioned for a fundamentals-led move. Strong free cash flow, healthy returns on equity, bullish technicals and fading meme-stock attention create a favorable risk/reward for a mid-term long trade. Entry at $200.86, stop $180.00, target $250.00 over ~45 trading days.
Visa is using partnerships and new on‑chain rails to convert crypto disruption into incremental franchise growth. The company’s network economics, $21.2B in free cash flow and 51% ROE give it optionality to monetize Open USD and other tokenized-payment flows. We lay out a concrete long trade with entry, stop and target, plus catalysts and risks.
I added MercadoLibre (MELI) as my third-largest position after a sizable pullback. The business combines high-growth e-commerce with an expanding fintech moat, generates meaningful free cash flow, and trades at a premium but not an extreme multiple for its growth. This is an actionable long with entry at $1807.13, a stop at $1520.00 and a primary t…
Zoom trades around $85 and looks cheap given $7+ EPS power, a market cap near $24.9B, and an indirect position in Anthropic. The risk-reward favors a disciplined long: entry $85.02, stop $75.00, target $110.00 over a 180-trading-day horizon, with clear catalysts and a finite list of risks to monitor.
Columbus McKinnon (CMCO) is a cyclical, highly leveraged industrial whose shares trade well below prior highs after a sharp reset. The business still generates industrial exposure, a modest dividend and a reasonable market-cap base ($404M) while enterprise value sits north of $2.6B because of leverage. This trade idea looks for a mid-term rebound t…
Meta’s announcement that it will commercialize excess AI infrastructure as Meta Compute sent shares through a volatile week. The market punished the stock on capex concerns; I see the move as an overreaction. Meta still prints strong ad growth, generates $48.3B in free cash flow, and trades at ~21x earnings with a $1.52T market cap. This is a mediu…
Jensen Huang's recent push against bespoke ASICs has exposed Nvidia to renewed competitive, pricing and regulatory risk. We are downgrading the stock and proposing a mid-term short: entry at $680.00, target $520.00, stop loss $760.00. The trade targets a re-rating driven by demand shifts, ASP pressure and coalition-driven customer negotiation.
Allegro is a niche leader in sensor and high-voltage power ICs that stands to benefit from a shift to 800-VDC architectures across EVs, robotics and industrial systems. Strong top-line execution, healthy free cash flow and improving leadership bench make a buyable setup after recent consolidation. The trade below balances upside toward the 52-week …
Palantir has the revenue growth, margins and cash-flow profile that can support a dramatically higher equity value if AIP achieves commercial scale. At $132.62 today we lay out a concrete trade: entry $132.62, target $602.00 (ambitious multi-year target consistent with ~40% annualized returns through 12/31/2030), stop $102.00. The trade is high-ris…
Avio is a leveraged, high-beta play on Europe’s sovereign space agenda. With Vega family upgrades, a growing pipeline of European institutional demand, and near-term contract catalysts, this is a speculative buy for risk-tolerant investors looking for asymmetric upside. Use tight sizing and a well-defined stop - this is a high-risk, event-driven tr…
EOS is a closed-end equity income fund trading near the low end of its 52-week range with an 8.29% yield, a sub-1.0 PB and a single-digit P/E. For yield seekers comfortable with CEF dynamics, a mid-term long (45 trading days) offers upside to the 52-week high while collecting monthly distributions. Manage position size around the stop and keep an e…
Tenax Therapeutics (TENX) has run up into a near-term data event for TNX-103. The balance sheet looks clean, market cap is light-moderate for a Phase 3 biotech, and technical momentum is strong. That combination argues for a Hold for existing holders and a cautious, size-limited long only on a defined pullback or with tight stops ahead of the Augus…
Meta's plan to sell excess AI compute as 'Meta Compute' reframes expensive data-center capex from a pure cost sink into a revenue generator. Combined with a still-robust Family of Apps business (33% y/y revenue growth cited in recent coverage) and attractive cash flow ($48.25B FCF), the stock looks primed for a re-rating. This is a swing trade idea…
Energy Transfer (ET) is a classic dip-and-buy candidate right now. The units trade near $19.34, yield roughly 7% with a $1.35 annual distribution, and sit below the 50-day moving average but above short-term EMAs as momentum quietly turns constructive. Fundamentals - free cash flow of $3.615B, EV/EBITDA ~8.6 and a market cap near $66.6B - give a re…
Nvidia has the balance sheet, cash flow and market position to monetize a newly accessible $200 billion opportunity in AI infrastructure. The stock is trading below key moving averages after a recent pullback; this trade targets a retest of the prior highs while keeping downside contained with a disciplined stop. Valuation is rich, so sizing and an…
Meta is down from its 52-week highs but fundamentals remain intact: double-digit revenue growth, healthy free cash flow, a clean balance sheet and a plausible new cloud revenue stream. This trade idea lays out an entry at current levels, a protective stop and a realistic upside target over a 180-trading-day horizon while flagging key risks that cou…
enCore Energy is a small-cap uranium developer with in-situ recovery projects in the U.S. A successful project license renewal would materially de-risk the path to production and could trigger a rapid re-rating. This trade outlines an actionable entry, stop and targets around that event with clear time horizons and risk controls.
DXC is trading cheaply on traditional multiples despite positive free cash flow, improving technicals, and growing partnerships around AI and sovereign cloud. At current levels the risk-reward favors a long position to $16.45 over the next 180 trading days, with a protective stop below $8.50.
OR Royalties is shifting from scale-up to harvest mode: rising gold equivalent production guidance, a recent $115M portfolio buy that adds near-term ounces, and an 18% dividend bump point to accelerating cash returns. At a $5.77B market cap and a sub-$31 share price entry, the risk/reward looks attractive for a long-term trade with a tight stop.
AutoNation (AN) trades at roughly 10x earnings, 0.23x sales and a sub-3x price-to-book while producing high returns on equity. With a market cap near $6.3B and a capital-allocation story centered on returning cash to shareholders, the risk/reward favors a long-term (180 trading days) long. This trade lays out an entry at $187.00, a stop at $170.00 …
CoreWeave's unit economics are starting to inflect as capacity scales. The stock trades at $87.26 with a market cap near $47.6B while the business still posts negative free cash flow and high leverage. This trade idea backs a long position into signs of margin recovery, balanced by clear stops for competition and capital risks.
Boston Scientific (BSX) has plunged from last year's highs and now sits near multi-month support with attractive cash generation and a manageable balance sheet. This is a tactical long trade: enter near $44.20, limit risk with a $39.50 stop, and target $60 — a mid-term trade that leans on clinical wins, TAVR exposure and improving technical momentu…
